Oct 8, 2019 Webinar

How a Former Pharma Executive Is Moving the Clinical Trial Industry Forward

A Fireside Chat with Amit Gulwadi (Celgene/Bristol-Myers Squibb)

After four years at Celgene and nearly a decade at Bristol-Myers Squibb, Amit Gulwadi left pharma to join Saama as Senior Vice President, Clinical Innovations in 2018.

In this webinar, Amit explains how his direct knowledge of the problems that plague clinical trials are shaping his innovation roadmap. “Our goal at Saama is to remove the daily frustrations and distractions of clinical trial operations professionals,” Amit says. “These include always waiting for information, dealing with conflicting versions of ‘the truth,’ and constant management requests for updates.”

Gregory T. Simpson, Saama’s VP, Head of Marketing, leads a lively discussion on how Amit’s work is disrupting the industry. Topics include:

  • Predictive operational analytics that help managers anticipate issues, intervene earlier, and improve oversight
  • Patient data analytics that enable true cross-study analysis, without computer capacity limitations
  • Deep Learning Intelligent Assistant (DaLIA), an AI-based application that can generate instant answers, without the need for direct contact with medical monitors, data managers, SAS programmers, and other experts.

Gated - Webinars

  • Watch this Webinar Now

  • You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.